David Jarrard
Vice Chair of Research and Academic Affairs · University of Wisconsin Hospitals and Clinics
Credentials: · · ·
History
Research
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
New England Journal of Medicine · 2015 · 2,355 citations
Journal of Clinical Oncology · 2018 · 871 citations
E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas
Cancer Research · 1995 · 706 citations
31 papers · 4 as a resident
27 papers
26 papers · 6 as a fellow
12 papers
12 papers
10 papers · 2 as a resident
10 papers
10 papers
Grants
- 2015–2031
Sequence-Specific Hybridization Capture to Reveal the lncRNA Interactome in Prostate Cancer
National Cancer Institute · R01
PI · $3.4M · University of Wisconsin-Madison
- 2023–2030
University of Wisconsin Prostate SPORE
National Cancer Institute · P50
Contact PI · $8.5M · University of Wisconsin-Madison
- 2002–2014
Modulation of IGF-II Imprinting in the Aging Prostate
National Cancer Institute · R01
Contact PI · $2.5M · University of Wisconsin-Madison
- 2008–2009
Modulation Of IGF-II Imprinting in the Aging Prostate
National Cancer Institute · R56
Contact PI · $249.7K · University of Wisconsin-Madison
Clinical trials
- 2014–2019
Principal investigator · Completed · Phase 2
National Cancer Institute (NCI)
- 2012–2013
Principal investigator · Completed · Phase 2
Molecular Insight Pharmaceuticals, Inc.
- 2011–2014
Cholecalciferol and Genistein Before Surgery in Treating Patients With Early Stage Prostate Cancer
Principal investigator · Completed · Phase 2
National Cancer Institute (NCI)
- 2000–2011
S9917, Selenium in Preventing Cancer in Patients With Neoplasia of the Prostate
Study chair · Completed · Phase 3
SWOG Cancer Research Network